<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Conditioning regimen consisted of melphalan at high dose 200 mg/m
 <sup>2</sup> (MEL200) or with reduced dose 100 or 140 mg/m
 <sup>2</sup> (rMEL) according to the presence of organ dysfunctions (creatinine clearance ≤ 40 mL/min or subjective evaluation of the patient’s ability to receive high-dose melphalan). Prophylactic care included antiviral and antifungal prophylaxis, thromboprophylaxis before thrombocytopenia, and Caphosol® for mucositis prophylaxis.
</p>
